🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a research study to test the effectiveness of nab-paclitaxel + carb...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2016-06-07
Trial ID
NCT02716038
Treatments Being Tested
The purpose of this study was to evaluate whether copanlisib in combination...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-03
Trial ID
NCT02367040
Treatments Being Tested
Study E7389-E044-112 is a Phase 1 study designed to assess the safety, tole...
Status
Completed
Location
Royal Marsden Hospital
Start Date
2012-12-11
Trial ID
NCT01945710
Treatments Being Tested
This randomized phase III trial studies the side effects and how well diffe...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2008-10-13
Trial ID
NCT00785291
This 2 stage study will compare the pharmacokinetics and safety profile of ...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00930514
RATIONALE: Gefitinib may stop the growth of tumor cells by blocking some of...
Status
Terminated
Location
University of Nebraska Medical Center
Start Date
2004-01
Trial ID
NCT00483561
Treatments Being Tested
This is a phase 3, randomized, 2-arm, open-label, international trial evalu...
Status
Completed
Location
Multiple Locations
Start Date
2012-06-11
Trial ID
NCT01482962
Treatments Being Tested
This is a multicenter phase 2b study to evaluate the efficacy and tolerabil...
Status
Completed
Location
Karmanos Cancer Institute
Start Date
2019-07-17
Trial ID
NCT04028388
Treatments Being Tested
This study incorporates alisertib, the small-molecule inhibitor of Aurora A...
Status
Active Not Recruiting
Location
Lucille Packard Children's Hospital at Stanford University Medical Center
Start Date
2014-05-14
Trial ID
NCT02114229
EGFR is a potential target for new anticancer therapy in head and neck squa...
Status
Completed
Location
Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University
Start Date
2011-08
Trial ID
NCT01434394
Treatments Being Tested